Cargando…
Cerebral cortex dose sparing for glioblastoma patients: IMRT versus robust treatment planning
BACKGROUND: To date, patients with glioblastoma still have a bad median overall survival rate despite radiation dose-escalation and combined modality treatment. Neurocognitive decline is a crucial adverse event which may be linked to high doses to the cortex. In a planning study, we investigated the...
Autores principales: | Exeli, Ann-Katrin, Kellner, Daniel, Exeli, Lukas, Steininger, Phil, Wolf, Frank, Sedlmayer, Felix, Deutschmann, Heinz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801703/ https://www.ncbi.nlm.nih.gov/pubmed/29409516 http://dx.doi.org/10.1186/s13014-018-0953-x |
Ejemplares similares
-
Normal tissue complication models for clinically relevant acute esophagitis (≥ grade 2) in patients treated with dose differentiated accelerated radiotherapy (DART-bid)
por: Zehentmayr, Franz, et al.
Publicado: (2015) -
DART-bid for loco-regionally advanced NSCLC: Summary of acute and late toxicity with long-term follow-up; experiences with pulmonary dose constraints
por: Wurstbauer, Karl, et al.
Publicado: (2017) -
Evaluation of OAR dose sparing and plan robustness of beam-specific PTV in lung cancer IMRT treatment
por: Chang, Yu, et al.
Publicado: (2020) -
Target splitting in radiation therapy for lung cancer: further developments and exemplary treatment plans
por: Wurstbauer, Karl, et al.
Publicado: (2009) -
Evaluation of plan quality and robustness of IMPT and helical IMRT for cervical cancer
por: Shang, Haijiao, et al.
Publicado: (2020)